72/100BAllstate Corp (The) stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Allstate Corp (The) is 268.29, 0.3% below the current price of 268.98. Their targets range from 221.00 to 319.00.
Of the 21 firms that rated Allstate Corp (The) in the past 12 months, 8 rate it buy or strong buy, 10 hold and 3 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 221.00 to 319.00, with an average of 268.29.
| Buy | 8 | |
| Hold | 10 | |
| Sell | 3 |
12-month price target
| Highest target | 319.00 |
| Average target | 268.29 |
| Lowest target | 221.00 |
| Current price | 268.98 |
Allstate Corp (The) price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Allstate Corp (The) price target and rating?
How analysts rate Allstate Corp (The), month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
8 of 21 firms rate it buy now, against 9 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Allstate Corp (The) analyst upgrades, downgrades and price targets
The latest rating change came on 12 October 2026, when Wells Fargo upgraded Allstate Corp (The) from Underweight to Equal Weight. Its price target is 236.00, from 250.00. The most recent new target came from Piper Sandler on 9 November 2026: 294.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 9 Nov 2026 | Piper Sandler Paul Newsome | Reiterated · Overweight | 268.00 → 294.00 | +9.7% | 252.19 |
| 12 Oct 2026 | Wells Fargo Elyse Greenspan | Upgraded · Underweight → Equal Weight | 250.00 → 236.00 | -5.6% | 229.43 |
| 7 Oct 2026 | Mizuho Securities | Reiterated · Outperform | 300.00 → 295.00 | -1.7% | 224.27 |
| 7 Oct 2026 | Barclays Alex Scott | Reiterated · Underweight | 226.00 → 221.00 | -2.2% | 224.27 |
| 7 Oct 2026 | HSBC | — | 264.00 → 266.00 | +0.8% | 224.27 |
| 1 Oct 2026 | Goldman Sachs | Reiterated · Neutral | 280.00 → 250.00 | -10.7% | 221.86 |
| 18 Sept 2026 | Mizuho Securities | Reiterated · Outperform | 297.00 → 300.00 | +1.0% | 252.21 |
| 16 Sept 2026 | Mizuho Securities | Reiterated · Outperform | 272.00 → 297.00 | +9.2% | 257.21 |
| 28 Aug 2026 | Argus Research Kevin Heal | Downgraded · Buy → Hold | 238.00 | — | 257.62 |
| 20 Aug 2026 | Keefe, Bruyette & Woods | Downgraded · Market Perform → Underperform | — | — | — |
| 11 Aug 2026 | Morgan Stanley | — | 240.00 → 265.00 | +10.4% | 267.77 |
| 11 Aug 2026 | Raymond James | — | 300.00 → 315.00 | +5.0% | 266.31 |
| 11 Aug 2026 | Citigroup | Downgraded · Neutral → Sell | — | — | — |
| 10 Aug 2026 | UBS | Reiterated · Neutral | 261.00 → 275.00 | +5.4% | 271.07 |
| 7 Aug 2026 | Goldman Sachs Robert Cox | — | 238.00 → 280.00 | +17.6% | 275.11 |
| 7 Aug 2026 | Wells Fargo | Downgraded · Equal Weight → Underweight | 228.00 → 250.00 | +9.6% | 275.11 |
| 7 Aug 2026 | Freedom Broker | Upgraded · Hold → Buy | — | — | — |
| 6 Aug 2026 | Roth Capital | Reiterated · Buy | 275.00 → 300.00 | +9.1% | 264.59 |
| 6 Aug 2026 | Barclays Alex Scott | Reiterated · Underweight | 213.00 → 226.00 | +6.1% | 264.59 |
| 17 Jul 2026 | Roth Capital | — | 240.00 → 275.00 | +14.6% | 248.55 |
| 15 Jul 2026 | Atlantic Equities | — | 319.00 | — | 240.55 |
| 15 Jul 2026 | UBS | Downgraded · Buy → Neutral | 250.00 → 261.00 | +4.4% | 250.35 |
| 10 Jul 2026 | Evercore ISI David Motemaden | Reiterated · Outperform | 225.00 → 240.00 | +6.7% | 250.59 |
| 9 Jul 2026 | Cantor Fitzgerald Ryan Tunis | Reiterated · Neutral | 242.00 | — | 249.27 |
| 9 Jul 2026 | Mizuho Securities | Reiterated · Outperform | 281.00 → 272.00 | -3.2% | 251.17 |
| 7 Jul 2026 | Barclays Alex Scott | Reiterated · Underweight | 198.00 → 213.00 | +7.6% | 248.37 |
| 6 Jul 2026 | Raymond James | Reiterated · Strong Buy | 260.00 → 300.00 | +15.4% | 248.04 |
| 6 Jul 2026 | Morgan Stanley Bob Huang | Reiterated · Equal Weight | 215.00 → 240.00 | +11.6% | 250.33 |
| 6 Jul 2026 | HSBC Vikram Gandhi | Downgraded · Buy → Hold | 264.00 | — | 250.33 |
| 8 Jun 2026 | Keefe, Bruyette & Woods | Downgraded · Outperform → Market Perform | — | — | — |
| 1 May 2026 | Piper Sandler | Reiterated · Overweight | 268.00 | — | 217.26 |
| 3 Mar 2026 | Raymond James Gregory Peters | — | 250.00 → 260.00 | +4.0% | 213.61 |
| 9 Feb 2026 | Mizuho Securities | Reiterated · Outperform | 255.00 → 281.00 | +10.2% | 207.55 |
| 7 Feb 2026 | Goldman Sachs | — | 227.00 → 238.00 | +4.8% | 207.55 |
| 6 Feb 2026 | Wells Fargo Elyse Greenspan | Reiterated · Equal Weight | 223.00 → 228.00 | +2.2% | 212.13 |
| 14 Jan 2026 | Mizuho Securities | — | 254.00 → 255.00 | +0.4% | 197.65 |
| 13 Jan 2026 | Wells Fargo | Reiterated · Equal Weight | 202.00 → 223.00 | +10.4% | 208.66 |
| 12 Jan 2026 | TD Cowen | Downgraded · Buy → Hold | — | — | — |
| 7 Jan 2026 | Goldman Sachs | — | 227.00 | — | 207.27 |
| 7 Jan 2026 | Evercore ISI | — | 233.00 → 225.00 | -3.4% | 208.97 |
| 18 Dec 2025 | William Blair | Downgraded · Outperform → Market Perform | — | — | — |
| 16 Dec 2025 | Morgan Stanley Bob Huang | Downgraded · Overweight → Equal Weight | 215.00 | — | 211.69 |
| 15 Dec 2025 | Mizuho Securities Yaron Kinar | — | 254.00 | — | 211.69 |
| 26 Nov 2025 | Roth Capital Harry Fong | Reiterated · Buy | 230.00 → 240.00 | +4.3% | 212.65 |
Allstate Corp (The) EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
EPS
Does Allstate Corp (The) beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 84.3% off the result, either way, and their revenue estimate 10.9%, over the last 12 quarters.
- EPS beats
- 100 / 134
- Revenue beats
- 101 / 120
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +84.3%
- Since
- September 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 4 Nov 2026 | 6.89 | 9.76 | +41.7% | 15.87B | 17.35B | +9.3% |
| Q2 FY2026 | 5 Aug 2026 | 6.06 | 8.99 | +48.3% | 15.46B | 15.43B | -0.2% |
| Q1 FY2026 | 29 Apr 2026 | 7.31 | 10.65 | +45.7% | 15.07B | 14.63B | -2.9% |
| Q4 FY2025 | 4 Feb 2026 | 9.83 | 14.31 | +45.6% | 14.53B | 14.57B | +0.3% |
| Q3 FY2025 | 5 Nov 2025 | 7.67 | 11.17 | +45.6% | 15.68B | 17.06B | +8.8% |
| Q2 FY2025 | 30 Jul 2025 | 3.25 | 5.94 | +82.8% | 15.21B | 16.62B | +9.3% |
| Q1 FY2025 | 30 Apr 2025 | 2.52 | 3.53 | +40.1% | 14.05B | 16.46B | +17.1% |
| Q4 FY2024 | 5 Feb 2025 | 5.40 | 7.67 | +42.0% | 13.72B | 16.51B | +20.3% |
| Q3 FY2024 | 30 Oct 2024 | 2.36 | 3.91 | +65.7% | 14.57B | 16.63B | +14.1% |
| Q2 FY2024 | 31 Jul 2024 | 0.28 | 1.61 | +478.3% | 14.04B | 15.71B | +11.9% |
| Q1 FY2024 | 1 May 2024 | 3.94 | 5.13 | +30.2% | 12.76B | 15.26B | +19.6% |
| Q4 FY2023 | 7 Feb 2024 | 3.99 | 5.82 | +45.9% | 12.69B | 14.83B | +16.8% |
Allstate Corp (The) stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Allstate Corp (The)'s earnings keep growing at the -7.7% a year analysts expect to FY2028, it would earn about 23.42 a share in FY2030. At the P/E it has traded at over the last five years (5.4 to 23.3) that is 126.01 to 546.59 a share, or 268.90 at its average P/E of 11.5. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 38.78 | 208.69 | 445.35 | 905.27 |
| FY2027 | 28.59 | 153.87 | 328.36 | 667.46 |
| FY2028 | 27.48 | 147.90 | 315.62 | 641.56 |
| FY2029 (extrapolated) | 25.37 | 136.51 | 291.32 | 592.17 |
| FY2030 (extrapolated) | 23.42 | 126.01 | 268.90 | 546.59 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow -7.7% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (5.4, 11.5, 23.3).
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 235.690 | 464.49205Price 235.69627 | +97.1% | |
| 28.860 | 56.2634Price 28.8696 | +94.9% | |
| 199.110 | 384.58163Price 199.112,644 | +93.1% | |
| 123.990 | 237.24178Price 123.99297 | +91.3% | |
| 157.820 | 297.58169Price 157.82471 | +88.6% | |
| 162.670 | 305.52160Price 162.67396 | +87.8% | |
| 216.610 | 405.38304Price 216.61507 | +87.1% |
Furthest below the fair value on each stock's page, updated every day.